Erika A Waters1, Ying Liu, Mario Schootman, Donna B Jeffe. 1. Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA. waterse@wudosis.wustl.edu
Abstract
BACKGROUND: Worry about cancer progression and perceived social support can affect cancer survivors' quality of life (QOL). METHODS: In 480 early-stage breast cancer survivors, we examined how worry about cancer progression and perceived social support 6 months after definitive surgery were associated with QOL (RAND 36-item Health Survey) at 6-, 12-, and 24-month follow-up. RESULTS: At 6 months post-surgery, higher worry was associated with worse QOL for five of eight subscales. Lower social support was associated with worse QOL for four subscales. The negative effects of worry and limited social support dissipated for four subscales (worry) and two subscales (social support) by 12-month follow-up and for all subscales by 24-month follow-up. Social support at 6 months moderated the relationship between T2 worry and T4 emotional well-being; post hoc tests did not clarify the nature of the interaction. CONCLUSION: Early-stage breast cancer survivors who worry about cancer progression and/or have low social support may experience lower levels of QOL that can take several months to resolve.
BACKGROUND: Worry about cancer progression and perceived social support can affect cancer survivors' quality of life (QOL). METHODS: In 480 early-stage breast cancer survivors, we examined how worry about cancer progression and perceived social support 6 months after definitive surgery were associated with QOL (RAND 36-item Health Survey) at 6-, 12-, and 24-month follow-up. RESULTS: At 6 months post-surgery, higher worry was associated with worse QOL for five of eight subscales. Lower social support was associated with worse QOL for four subscales. The negative effects of worry and limited social support dissipated for four subscales (worry) and two subscales (social support) by 12-month follow-up and for all subscales by 24-month follow-up. Social support at 6 months moderated the relationship between T2 worry and T4 emotional well-being; post hoc tests did not clarify the nature of the interaction. CONCLUSION: Early-stage breast cancer survivors who worry about cancer progression and/or have low social support may experience lower levels of QOL that can take several months to resolve.
Authors: Ying Liu; Maria Pérez; Mario Schootman; Rebecca L Aft; William E Gillanders; Matthew J Ellis; Donna B Jeffe Journal: Breast Cancer Res Treat Date: 2010-05-06 Impact factor: 4.872
Authors: Ying Liu; Maria Pérez; Rebecca L Aft; Kerry Massman; Erica Robinson; Stephanie Myles; Mario Schootman; William E Gillanders; Donna B Jeffe Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-02-16 Impact factor: 4.254
Authors: Salene M W Jones; Rebecca Ziebell; Rod Walker; Larissa Nekhlyudov; Borsika A Rabin; Stephanie Nutt; Monica Fujii; Jessica Chubak Journal: Support Care Cancer Date: 2016-12-15 Impact factor: 3.603
Authors: Li Wang; Gordon H Guyatt; Sean A Kennedy; Beatriz Romerosa; Henry Y Kwon; Alka Kaushal; Yaping Chang; Samantha Craigie; Carlos P B de Almeida; Rachel J Couban; Shawn R Parascandalo; Zain Izhar; Susan Reid; James S Khan; Michael McGillion; Jason W Busse Journal: CMAJ Date: 2016-07-11 Impact factor: 8.262
Authors: Laurence Leysen; Astrid Lahousse; Jo Nijs; Nele Adriaenssens; Olivier Mairesse; Sergei Ivakhnov; Thomas Bilterys; Eveline Van Looveren; Roselien Pas; David Beckwée Journal: Support Care Cancer Date: 2019-07-25 Impact factor: 3.603
Authors: Nancy K Janz; Christopher R Friese; Yun Li; John J Graff; Ann S Hamilton; Sarah T Hawley Journal: J Cancer Surviv Date: 2013-11-13 Impact factor: 4.442
Authors: Sophie Lebel; Sebastien Simard; Cheryl Harris; Andrea Feldstain; Sara Beattie; Megan McCallum; Monique Lefebvre; Josée Savard; Gerald M Devins Journal: Qual Life Res Date: 2015-09-04 Impact factor: 4.147
Authors: Juan Ignacio Arraras; Jose Juan Illarramendi; Esteban Salgado; Susana de la Cruz; Gemma Asin; Ana Manterola; Berta Ibañez; Uxue Zarandona; Miguel Angel Dominguez; Ruth Vera Journal: Contemp Oncol (Pozn) Date: 2016-06-14